Investor List:

Top Drug Delivery Series A Investors (87)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Drug Delivery investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James Wang, General Partner at Creative Ventures
James Wang
Creative Ventures·General Partner
Sweet spot: $750K
Range: $250K - $1M
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Cybersecurity (Seed), Investors in Medical Devices (Seed), Investors in Diagnostics (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Cybersecurity (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Cybersecurity (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Robotics (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Cybersecurity (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in New York City (Other Lists)
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in EnergyTech (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Drug Delivery (Series A), Investors in AgTech (Series A), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in EnergyTech (Series A), Investors in DeepTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in EnergyTech (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
Photo of Ben York, Investor at Ensemble Brands
Ben York
Ensemble Brands·Investor
Sweet spot: $100K
Range: $50K - $250K
Photo of Peter Parker, Managing Partner at Mission BioCapital
Peter Parker
Mission BioCapital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Washington, D.C. (Other Lists)
Photo of Greg Kubin, General Partner at PsyMed Ventures
Greg Kubin
PsyMed Ventures·General Partner
Sweet spot: $250K
Range: $100K - $2.0M
KK
Kelvin Keh
Covalent Ventures·Managing Partner
Sweet spot: $2.0M
Range: $500K - $4.0M
Investors in Thailand, Investors in Indonesia, Investors in Boston (MA), Investors in San Francisco (CA), Investors in Singapore, Investors in Sydney (Australia), Investors in Melbourne (Australia), Investors in New Zealand
Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Wellness & Fitness (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Food and Beverage (Series A), Investors in Diagnostics (Series A), Investors in Impact (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Food and Beverage (Series A), Investors in Diagnostics (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Impact (Series A), Investors in Health IT (Series A), Investors in Wellness & Fitness (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diverse Investors (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)